SEC FORM 4
$346,086.48
Monopar Therapeutics (MNPR)
Disposition (code F) of 4,344 shares at $79.67 per share.
Reporting Person Robinson Chandler · Officer Title Chief Executive Officer · Transaction Code F
Traded Sep 30, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001437749-26-031925 · filed 2026-10-02 · View filing →